| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $56K | — | +32.6% |
| Cost of Revenue | $46K | — | +57.3% |
| Gross Profit | $10K | — | -21.5% |
| R&D Expense | $142 | — | -99.4% |
| Operating Income | -$661K | — | +28.9% |
| Interest Expense | $22K | — | — |
| Pre-tax Income | -$2.5M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $27K | +24.1% | -44.3% |
| Inventory | $115K | -2.1% | +927.1% |
| Current Assets | $269K | -38.6% | -39.8% |
| Total Assets | $727K | -6.0% | -39.3% |
| Current Liabilities | $41.0M | +2.0% | +20.7% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$460K | — | +36.6% |
| Capital Expenditures | $3K | — | +0.0% |
| Investing Cash Flow | -$175K | — | -4914.3% |
| Financing Cash Flow | $452K | — | +73.3% |
| Free Cash Flow | -$463K | — | +36.4% |
| -59.5% |
| Net Income | -$2.5M | — | -59.5% |
| EPS (Basic) | -$0.80 | — | — |
| EPS (Diluted) | -$0.80 | — | — |
| $41.1M |
| +2.0% |
| +20.8% |
| Stockholders' Equity | -$39.6M | -2.2% | -23.6% |